1000 sample comparison of MLPA and RT-PCR for carrier detection and diagnostic testing for Spinal Muscular Atrophy Type 1

Journals Menu

Follow SCIRP

ISSN Print: 2162-4453
ISSN Online: 2162-4461
www.scirp.org/journal/ojgen
E-mail: ojgen@scirp.org

Citations h5-index & Ranking*

"1000 sample comparison of MLPA and RT-PCR for carrier detection and diagnostic testing for Spinal Muscular Atrophy Type 1"
written by Charles M. Strom, Ben Anderson, Mei Peng, Urjit Patel, Corey D. Braastad, Weimin Sun,
published by Open Journal of Genetics, Vol.3 No.2, 2013

has been cited by the following article(s):

[1]	New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study
	International Journal of …, 2022

[2]	SMA carrier testing using Real-time PCR as a potential preconception screening tool
	Egyptian Journal of …, 2022

[3]	Newborn screening for 5q spinal muscular atrophy: comparisons between real-time PCR methodologies and cost estimations for future implementation programs
	International journal of …, 2021

[4]	Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots
	2020

[5]	Spinal muscular dystrophy–a revisit of the diagnosis and treatment modalities
	2019

[6]	High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR
	2019

[7]	Spinal muscular atrophy–a revisit of the diagnosis and treatment modalities
	2019

[8]	Relationships between long-term observations of motor milestones and genotype analysis results in childhood-onset Japanese spinal muscular atrophy patients
	Brain and Development, 2017

[9]	Copy Number Variation Analysis by Ligation-Dependent PCR Based on Magnetic Nanoparticles and Chemiluminescence
	Theranostics, 2015

[10]	Copy number variation analysis by ligation-dependent PCR based on magnetic nanoparticles and chemiluminescence.
	Theranostics, 2014

[1]	Validation of SMA screening kits with SMN1 gene analysis in a Turkish cohort Clinica Chimica Acta, 2024 DOI:10.1016/j.cca.2024.117793

[2]	New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study International Journal of Neonatal Screening, 2022 DOI:10.3390/ijns8010015

[3]	SMA carrier testing using Real-time PCR as a potential preconception screening tool Egyptian Journal of Medical Human Genetics, 2022 DOI:10.1186/s43042-022-00233-9

[4]	Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs International Journal of Neonatal Screening, 2021 DOI:10.3390/ijns7030053

[5]	Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots International Journal of Neonatal Screening, 2020 DOI:10.3390/ijns6020043

[6]	High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR European Journal of Human Genetics, 2019 DOI:10.1038/s41431-019-0476-4

[7]	Spinal muscular dystrophy – a revisit of the diagnosis and treatment modalities International Journal of Neuroscience, 2019 DOI:10.1080/00207454.2019.1635128

[8]	Relationships between long-term observations of motor milestones and genotype analysis results in childhood-onset Japanese spinal muscular atrophy patients Brain and Development, 2017 DOI:10.1016/j.braindev.2017.04.018

Follow SCIRP